senwayer tirzepatide Zepbound (tirzepatide) superior to Wegovy (semaglutide), says Lilly-funded clinical trial FDA says the tirzepatide weight-loss

Collectively, these findings suggest that the metabolic effects of GLP-1 receptor agonists may be preserved despite advanced renal dysfunction, although robust randomized data in ESRD remain lacking

Your bodys endocrine system (hormones) is changing

Most patients regain two-thirds of lost weight within one year

Int J Obes 2009

Be sure to consult your healthcare provider if you have questions or concerns about consuming Ozempic and coffee or Zepbound and coffee and other GLP-1 medications and coffee or alcohol and GLP-1 medications

This makes it a valuable advanced obesity drug for those struggling with stubborn belly fat